Skip to main content
Veterinary Medicines

Belacol 100 % Compactate

Authorised
  • COLISTIN SULFATE

Product identification

Medicine name:
Belacol 100 % Compactate
Belacol 1000 mg/g, κοκκία για χρήση στο πόσιμο νερό για βοοειδή, χοίρους και ορνίθια
Active substance:
  • COLISTIN SULFATE
Target species:
  • Cattle
  • Chicken
  • Pig
Route of administration:
  • In drinking water/milk use

Product details

Active substance and strength:
  • COLISTIN SULFATE
    1000.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Granules for use in drinking water
Withdrawal period by route of administration:
  • In drinking water/milk use
    • Cattle
      • Meat and offal
        1
        day
    • Chicken
      • Meat and offal
        1
        day
    • Pig
      • Meat and offal
        1
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA10
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:
  • 1 kg in fold-up carton with inner layer (paper/PE/Alu/PE)
  • 250 g in fold-up carton with inner layer (paper/PE/Alu/PE)
  • 2.5 kg in kard-o-seal-bag (PE/paper/PE/Alu/PE)
  • 500 g in fold-up carton with inner layer (paper/PE/Alu/PE)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bela-Pharm GmbH & Co. KG
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 105060/08-11-2021
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0199/001
Concerned member states:
  • Croatia
  • Estonia
  • Greece
  • Hungary
  • Latvia
  • Lithuania
  • Slovakia

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 25/05/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."